Fiona du Monceau - de Hemptinne

Fiona du Monceau - de Hemptinne has a wealth of experience in various roles within the pharmaceutical and business sectors. Fiona currently serves as the Chief Operating Officer and Chief Financial Officer at ExeVir, and previously held positions at UCB, Eli Lilly and Company, McKinsey & Company, Eurogentec, GlaxoSmithKline, and LG-Philips LCD. Fiona holds an MBA from Harvard Business School and an MSc from Solvay Brussels School of Economics and Management.